This marks omalizumab’s fourth FDA-approved indication for allergic and inflammatory conditions, such as severe persistent allergic asthma, with its initial approval being in 2003.
The permission from the U.S. Food and Drug Administration marks Xolair as the basic and lone medication for individuals dealing with one or more food allergies. This arrangement follows clinical exploratory data on the injectable asthma medication, demonstrating its validity in reducing food-related hypersensitivity reactions.
(CNN) — The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic
FDA Approves Xolair as First and Only Medicine for Children and Adults With One or More Food Allergies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Approval is based on data from the NIH-sponsored Phase III OUtMATCH study, which showed a significantly higher proportion of food allergy patients as young.